Search for: "Merck & Cie"
Results 1 - 20
of 21
Sorted by Relevance
|
Sort by Date
16 May 2016, 9:59 pm
§ 102(b) in Merck & Cie v. [read post]
17 Dec 2015, 9:59 pm
Patent and Trademark Office in an inter partes review by the Patent Trial and Appeal Board in Merck & Cie v. [read post]
19 Feb 2012, 8:55 pm
Merck & Cie et al. v. [read post]
11 Sep 2012, 4:30 pm
On September 10, 2012, South Alabama Medical Science Foundation of Mobile, Alabama (“SAMSF”), Merck & Cie of Switzerland (“Merck”), and Pamlab LLC of Covington, Louisiana (“Pamlab”) (collectively, the “Complainants”) filed a complaint requesting that the ITC commence an investigation pursuant to Section 337. [read post]
8 Mar 2016, 9:19 pm
Merck & Cie et al. v. [read post]
24 Nov 2016, 8:23 pm
The petition of the day is: Merck & Cie v. [read post]
22 Jul 2014, 9:59 pm
("Gnosis") (Petitioner) and either Merck & Cie ("Merck") (Patent Owner in IPR2013-00117) or South Alabama Medical Science Foundation ("SAMSF") (Patent... [read post]
14 Jul 2018, 9:30 pm
John Duffy of the University of Virginia, Jennifer Johnson of DuPont, and Christopher Loh of Fitzpatrick, Cella, Harper & Scinto will review the current status quo after two significant Federal Circuit decisions in recent years on the on-sale and public use bars, Merck & CIE v. [read post]
26 Apr 2016, 8:44 am
by Dennis Crouch En banc denials in Merck & Cie v. [read post]
14 May 2016, 6:24 am
§ 102(b) (2006).1 See Merck & Cie v. [read post]
14 Nov 2016, 9:16 am
by Dennis Crouch Substantive Patent Law: Newly filed petition in Merck & Cie v. [read post]
5 Oct 2012, 7:07 am
Sullivan ruled in favor of Merck Eprova AG (n/k/a Merck & Cie) in its 2007 false advertising lawsuit against Gnosis S.P.A. and Gnosis Bioresearch SA (“Gnosis”). [read post]
20 Feb 2012, 1:26 am
Watson has been trying to make a generic version of Beyaz that is said to be in violation of the patent... at least that is according to Bayer and its partner Merck & Cie. [read post]
21 Aug 2014, 10:30 am
Since 2002, Merck & Cie (“Merck”)[2] manufactured and sold a folate product under the name “Metafolin” to customers who utilize it in finished products for resale, such as vitamins and supplements. [read post]
21 Aug 2014, 10:38 am
Since 2002, Merck & Cie (“Merck”)[2] manufactured and sold a folate product under the name “Metafolin” to customers who utilize it in finished products for resale, such as vitamins and supplements. [read post]
16 Jan 2017, 5:44 pm
., No. 16-332 (effectively extending exclusivity to 12 1/2 years; complement to the Sandoz petition) Anticipation/Obviousness: Merck & Cie, et al. v. [read post]
8 Feb 2017, 3:09 am
., No. 16-332 (effectively extending exclusivity to 12 1/2 years; complement to the Sandoz petition) Anticipation/Obviousness: Merck & Cie, et al. v. [read post]
5 Sep 2016, 6:46 pm
Post Grant Admin: Merck & Cie, et al. v. [read post]
18 Sep 2016, 6:03 pm
Post Grant Admin: Merck & Cie, et al. v. [read post]
28 Sep 2016, 8:39 am
Post Grant Admin: Merck & Cie, et al. v. [read post]
